Fake Kidney Transplant Drug Sparks East Africa Alert

Kenya's drug regulator has warned the public about a falsified version of a critical transplant medication. The alert follows a notice from the World Health Organization (WHO). The Pharmacy and Poisons Board (PPB) identified the fake drug as SIMULECT (basiliximab). This medication is essential for preventing a patient's body from rejecting a newly transplanted kidney. The WHO first flagged the counterfeit product in Rwanda. Kenyan authorities are now on high alert to prevent its entry and distribution within the country. The PPB advises all healthcare providers, pharmacies, and patients to be extremely vigilant. They must check the authenticity of any SIMULECT supplies and report suspicious products immediately. Using falsified medicines poses a severe risk. For transplant patients, a counterfeit drug could lead to organ rejection, organ failure, or death.